Previous 10 | Next 10 |
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced the filing of a premarket notification 510(k) to the U.S. Food and Drug ...
2023-12-30 10:50:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Company’s proprietary system used to treat initial five patients in first-in-human feasibility study for patients with atrial fibrillation Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ab...
2023-12-19 12:49:04 ET Gainers: Panbela Therapeutics ( PBLA ) +54% . Singlepoint ( SING ) +41% . MedAvail Holdings ( MDVL ) +32% . REE Automotive Ltd ( REE ) +29% . Pulse Biosciences ( PLSE ) +28% . Neonode ( NEON ) +25...
2023-12-19 12:24:05 ET DENVER, Colo., Dec. 19, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Compugen Ltd (NASDAQ: CGEN), Infobird Co Ltd (NASDAQ: IFBD), Mama`s Creations Inc (NASDAQ: MAMA), Panb...
2023-12-13 07:35:31 ET More on Pulse Biosciences Pulse Biosciences: Cash Flow Bleed Remains A Concern Ahead Of 2024 Catalysts Pulse Biosciences as chairman cleared to buy up to 1M stock Financial information for Pulse Biosciences For further details see: ...
2023-12-05 15:41:43 ET More on Pulse Biosciences Pulse Biosciences: Cash Flow Bleed Remains A Concern Ahead Of 2024 Catalysts Pulse Biosciences Q3 2023 Earnings Call Transcript Pulse Biosciences as chairman cleared to buy up to 1M stock Financial information ...
2023-11-27 14:14:39 ET More on Pulse Biosciences Pulse Biosciences: Cash Flow Bleed Remains A Concern Ahead Of 2024 Catalysts Pulse Biosciences, Inc. (PLSE) Q3 2023 Earnings Call Transcript Financial information for Pulse Biosciences For further details see: ...
2023-11-21 18:05:40 ET Summary Pulse Biosciences is seeking FDA clearance for its electromedical devices. The company's nanosecond pulsed field ablation technology is seen as superior to existing cardiac surgical tools on the market. While the product potential is encouraging,...
Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today announced the filing of a premarket notification 510(k) to the U.S. Food and Drug ...
News, Short Squeeze, Breakout and More Instantly...
Pulse Biosciences Inc Company Name:
PLSE Stock Symbol:
NASDAQ Market:
Pulse Biosciences Inc Website:
Pulse Biosciences, Inc. (Nasdaq: PLSE) (the “Company” or “Pulse Biosciences”), a company leveraging its novel and proprietary CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, announced today the closing of its rights offering and the fi...
2024-06-25 21:26:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-15 22:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...